Amedisys (AMED) Misses Q1 EPS by 1c; Withdraws Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Amedisys Reports First Quarter 2020 Financial Results
May 6, 2020 4:15 PM EDTBATON ROUGE, La., May 06, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2020.
Three-Month Periods Ended March 31, 2020 and 2019
Net service revenue increased $24.4Â million to $491.7Â million compared to $467.3Â million in 2019.Net income attributable to Amedisys, Inc. of $31.8Â million compared to $31.3Â million in 2019.Net income attributable to Amedisys, Inc. per diluted share of $0.96 compared to $0.95 in 2019.Adjusted Quarterly Results*
Adjusted EBITDA of $53.3Â million compared to $54.9Â million in 2019.Adjusted net service revenue of $491.7Â million compared to $467.8Â million in 2019.Adjusted net... More